• Vitamin D/VDR in Endometrial Decidualization

  2026-09-11

  The reference study shows that active vitamin D promotes human endometrial stromal cell decidualization through vitamin D receptor signaling, with CYP19-mediated estrogen production emerging as a central mechanism. Its combination of metabolic profiling, VDR perturbation, primary-cell validation, and ChIP-qPCR provides a mechanistic framework for studying endometrial receptivity and infertility-related biology.

• Dissolving Microneedles for Risedronate Delivery

  2026-09-11

  The reference study developed a gelatin dissolving microneedle patch containing Risedronate Sodium and ursolic acid nanotransfersomes to improve transdermal delivery for osteoporosis research. Its optimized vesicles showed high drug entrapment, sustained release, suitable microneedle performance, and substantial ex vivo skin permeation, although animal and clinical validation remain necessary.

• Zolmitriptan B2261: Reproducible Cell Assays

  2026-09-10

  A scenario-based guide to using Zolmitriptan, SKU B2261, in cell viability, proliferation, and cytotoxicity workflows. It explains formulation control, receptor-pharmacology interpretation, assay optimization, and practical supplier selection without overstating evidence.

• Letrozole: Mechanism-to-Assay Research Guide

  2026-09-10

  Letrozole is a reversible, non-steroidal aromatase inhibitor for dissecting estrogen biosynthesis, ERα signaling, and endocrine feedback. This guide connects molecular mechanism with assay architecture, interpretation, and research-use limitations.

• Spiroplasma Entry into Drosophila S2 Cells

  2026-09-09

  Wei et al. established a Drosophila Schneider 2 cell model showing that Spiroplasma eriocheiris invades host cells through clathrin-mediated endocytosis and macropinocytosis. Pharmacological perturbation further linked infection to intact actin filaments and microtubules, providing a useful framework for dissecting bacterial entry in an invertebrate system.

• Cholesterol’s Strategic Role in mRNA-LNP Therapy

  2026-09-09

  Cholesterol is more than a membrane ingredient: it is a controllable biophysical variable that may shape lipid nanoparticle performance in localized mRNA therapy. This thought-leadership article connects membrane biology, lipid metabolism research, and the preclinical p21 mRNA-LNP bladder cancer study to provide a practical framework for formulation validation and translational decision-making.

• Reversine for Reliable Cell Proliferation Assays

  2026-09-08

  Learn how Reversine (SKU A3760) can support better-controlled viability, proliferation, and cytotoxicity experiments through mechanism-aware dosing, solvent controls, and orthogonal readouts. This scenario-based guide connects Aurora kinase biology with practical assay optimization and vendor-selection criteria.

• JHU-083: Selective Glutaminase Research Guide

  2026-09-07

  JHU-083 is a 6-diazo-5-oxo-L-norleucine precursor and selective glutaminase antagonist for experimental cerebral malaria research. Product information links its activity in cerebral CD11b cells to reduced glutamate levels, while its specifications support glutaminase pathway research in neurological disease models.

• Octenidine Dihydrochloride: Assay Logic

  2026-09-07

  Octenidine dihydrochloride is a membrane-active antiseptic research compound whose value depends on more than endpoint potency. This guide connects molecular structure, formulation, controls, and recent gemini-quaternary-ammonium findings to improve antimicrobial assay interpretation.

• Deracoxib and Piroxicam in Canine Mammary Tumor Cells

  2026-09-05

  The reference study examined whether Deracoxib and piroxicam directly suppress canine mammary carcinoma cells, either alone or in combination. Its central finding was that combined treatment produced stronger viability loss, apoptosis, and G0/G1 cell-cycle accumulation than either drug alone, while also highlighting the limitations of translating high-concentration in vitro results to clinical therapy.

• MLN2238: Proteasome Stress Signaling

  2026-09-04

  MLN2238 is a potent proteasome β5 subunit inhibitor that enables a more informative view of proteotoxic stress than viability measurements alone. This article connects its catalytic-site selectivity with ROS–JNK–CREB signaling and provides a practical framework for oncology and proteostasis assays.

• Catalpol in Cardio-Cerebrovascular Disease Research

  2026-09-04

  The 2023 review frames Catalpol as a multi-pathway iridoid glucoside with antioxidant, anti-inflammatory, and anti-apoptotic activity across atherosclerosis, myocardial injury, cardiac remodeling, and related vascular disorders. Its main practical contribution is an integrated map linking disease phenotypes with signaling networks, while also identifying the limited clinical evidence and the need for better pharmacokinetic and translational studies.

• AAL-993: VEGF Receptor Inhibitor Workflow

  2026-09-04

  AAL-993 is a selective VEGF receptor inhibitor for separating VEGFR-driven angiogenesis from tumor-cell signaling in biochemical, endothelial, and mouse-model workflows. Its strong VEGFR-2 and VEGFR-3 activity makes it especially useful for mechanism-focused tumor angiogenesis research, including studies inspired by glioma and melanoma models.

• Phalloidin B7678: F-Actin Workflow Guide

  2026-09-03

  Phalloidin B7678 is a high-affinity F-actin probe for preserving and visualizing filament organization in fixed or permeabilized samples. It supports static cytoskeleton visualization but should not be used for live-cell imaging, reversible actin studies, or direct measurement of monomeric G-actin.

• Imidazoline Antagonists and β-Cell K+ Channels

  2026-09-02

  Jonas, Plant, and Henquin showed that several imidazoline α2-adrenoceptor antagonists stimulate insulin release primarily by inhibiting ATP-sensitive K+ channels in pancreatic β-cells, rather than simply by blocking adrenergic receptors. Their combination of insulin secretion assays, 86Rb efflux measurements, and patch-clamp recordings provides a useful framework for separating receptor-mediated effects from direct ion-channel actions.

8611 records 1/575 page Next 12345 下5页 Last page